Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-011700
Filing Date
2016-03-29
Accepted
2016-03-29 16:12:12
Documents
78
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2227875z10-k.htm 10-K 1478270
2 EX-23.1 a2227875zex-23_1.htm EX-23.1 3132
3 EX-31.1 a2227875zex-31_1.htm EX-31.1 7667
4 EX-31.2 a2227875zex-31_2.htm EX-31.2 8142
5 EX-32.1 a2227875zex-32_1.htm EX-32.1 4554
6 EX-32.2 a2227875zex-32_2.htm EX-32.2 5027
13 G679203.JPG g679203.jpg GRAPHIC 47656
14 G1031349.JPG g1031349.jpg GRAPHIC 39773
  Complete submission text file 0001047469-16-011700.txt   9738385

Data Files

Seq Description Document Type Size
7 EX-101.INS jagx-20151231.xml EX-101.INS 2320274
8 EX-101.SCH jagx-20151231.xsd EX-101.SCH 73607
9 EX-101.CAL jagx-20151231_cal.xml EX-101.CAL 77947
10 EX-101.DEF jagx-20151231_def.xml EX-101.DEF 314624
11 EX-101.LAB jagx-20151231_lab.xml EX-101.LAB 682603
12 EX-101.PRE jagx-20151231_pre.xml EX-101.PRE 530245
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Animal Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 161535537
SIC: 2834 Pharmaceutical Preparations